Targeted Radionuclide Therapy: New Advances for Improvement of Patient Management and Response. (2019)
Attributed to:
OxCD3: Oxford Centre for Drug Delivery Devices
funded by
EPSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.3390/cancers11020268
PubMed Identifier: 30823564
Publication URI: http://europepmc.org/abstract/MED/30823564
Type: Journal Article/Review
Volume: 11
Parent Publication: Cancers
Issue: 2
ISSN: 2072-6694